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Abstract
Background: Changes in the gene expressions for tumor necrosis factor-a (TNF-a) and/or interleukin-1b (IL-1b)
during tinnitus have not been previously reported. We evaluated tinnitus and mRNA expression levels of TNF-a, IL-
1b, and N-methyl D-aspartate receptor subunit 2B (NR2B) genes in cochlea and inferior colliculus (IC) of mice after
intraperitoneal injections of salicylate.
Methods: Forty-eight 3-month-old male SAMP8 mice were randomly and equally divided into two groups:
salicylate-treated and saline-treated. All mice were trained to perform an active avoidance task for 5 days. Once
conditioned, an active avoidance task was performed 2 hours after daily intraperitoneal injections of saline, either
alone or containing 300 mg/kg sodium salicylate. Total numbers of times (tinnitus score) the mice climbed during
the inter-trial silent period for 10 trials were recorded daily for 4 days (days 7 to 10), and then mice were
euthanized for determination of mRNA expression levels of TNF-a, IL-1b, and NR2B genes in cochlea and IC at day
10.
Results: Tinnitus scores increased in response to daily salicylate treatments. The mRNA expression levels of TNF-a
increased significantly for the salicylate-treated group compared to the control group in both cochlea (1.89 ± 0.22
vs. 0.87 ± 0.07, P < 0.0001) and IC (2.12 ± 0.23 vs. 1.73 ± 0.22, p = 0.0040). mRNA expression levels for the IL-1b
gene also increased significantly in the salicylate group compared to the control group in both cochlea (3.50 ±
1.05 vs. 2.80 ± 0.28, p < 0.0001) and IC (2.94 ± 0.51 versus 1.24 ± 0.52, p = 0.0013). Linear regression analysis
revealed a significant positive association between tinnitus scores and expression levels of TNF-a, IL-1b, and NR2B
genes in cochlea and IC. In addition, expression levels of the TNF-a gene were positively correlated with those of
the NR2Bgene in both cochlea and IC; whereas, the expression levels of the IL-1b gene was positively correlated
with that of the NR2B gene in IC, but not in cochlea.
Conclusion: We conclude that salicylate treatment resulting in tinnitus augments expression of the TNF-a and IL-
1b genes in cochlea and IC of mice, and we suggest that these proinflammatory cytokines might lead to tinnitus
directly or via modulating the NMDA receptor.
Background
Tinnitus is the perception of sound in the absence of
acoustic stimulation. Usually occurring together with
hearing loss, tinnitus can be perceived in one or both
ears, or in the head. Tinnitus is distinguishable from
auditory hallucinations, which involve hearing one or
more talking voices. Salicylate-induced tinnitus in mice
has been a popular animal model for the study of tinni-
tus [1]. The mechanism of salicylate-induced tinnitus is
postulated to involve accumulation of arachidonic acid
caused by inhibition of cyclooxygenase (COX) that
could potentiate N-methyl D-aspartate receptor (NR)
currents at synapses between inner hair cells and den-
drites of the cochlear spiral ganglion neuron [2].
Tinnitus-related changes in gene expression have been
recently reported. Microarray studies have revealed that
87 genes are up-regulated and 140 genes are down-regu-
lated by two-fold or more in mouse cochlea during
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any medium, provided the original work is properly cited.salicylate ototoxicity [3]. Jia and Qin [4] have reported
that expression of c-fos and NR2A increases in auditory
cortexes of rats that experience tinnitus after salicylate
injection. We also have found that mRNA expression
levels for COX-2 decrease slightly, whereas expression
levels of NR2B increase moderately in cochlea and mid-
brain of salicylate-treated, senescence accelerated prone
mice substrain 8 (SAMP8 mice) [5].
Recent studies have shown that inflammatory responses
occur in the inner ear under various damaging conditions,
including overstimulation with noise [6] and cisplatin-
induced ototoxicity [7]. However, an association between
proinflammatory cytokines and tinnitus has been rarely
reported. In chronic tinnitus sufferers, a relaxation training
program can result in significantly decreased stress,
anxious depression, anger, and tinnitus disturbance, paral-
leled by a reduction of TNF-a, but not IL-6 or IL-10 [8].
Also, previous studies have shown that TNF-a and IL-1b
might interact with the NR [9-12] in inflammatory hyper-
algesia [13], bone cancer pain [14], seizures [15], vision
loss [16], and spinal cord injury [17]. Because the NR is
also linked to tinnitus in rats [2] and mice [5], we hypothe-
sized that tinnitus may be associated with changes in gene
expression of these proinflammatory cytokines.
A p a r tf r o mt h e“theory of cochlear origin” [18], tinni-
tus is most commonly believed to originate from the
central nervous system. Positron emission tomography
has shown increased metabolic activity consistent with
neuronal activation in the inferior colliculus (IC) and in
the auditory cortices of rats with salicylate-induced tin-
nitus [19]. Thus, we sought to assess gene expressions
in cochlea and IC for this study.
Methods
Animals
Because tinnitus is most prevalent in older humans, we
used the SAMP8 mice for this study, although other
strains of rodents, cats, or rabbits could also have been
used. Forty-eight 3-month-old male SAMP8 mice,
weighing between 22 and 33 g, were randomly and
equally divided into two groups: salicylate-treated (n =
24) and saline-treated (n = 24). Our Institutional Animal
Care and Use Committee approved the protocols used
in this study.
Behavioral measurement of tinnitus score
All mice were trained to perform an active avoidance
task, which was performed in a conditioning box with
an electrical floor and a climbing pole, according to the
design of Guitton et al. [2].
Conditioning to the task
The conditioning paradigm consisted of 6 sessions per-
formed daily for 5 days (day 1 to 5). Each session lasted
15 to 20 min, and there were 10 trials per session.
Inter-trial intervals were at least 1 minute. For each
trial, the conditioning stimulus was a 50 dB sound pres-
sure level (SPL) pure tone with a frequency of 10 k Hz
and a 3-second duration. The unconditioned stimulus
was a 3.7 mA electric foot-shock presented for up to
30 seconds, as described by Guitton’sp r o t o c o l[ 2 ] ,b y
adjusting the electric voltage with fixed copper wire
resistance on the floor. The time between the condi-
tioned stimulus and the unconditioned stimulus was
1 second. The mice would climb up the pole to a safe
area after the coupled conditioned and unconditioned
stimuli. Electrical shocks were stopped by the experi-
menter when the animal climbed correctly. The “true-
positive” score was the level of performance as assessed
by the number of times the mice climbed correctly in
response to sound. Mice were considered to be condi-
tioned when the “true-positive” score reached at least
80% in three consecutive sessions. Only conditioned
mice entered the tinnitus experiments.
Induction and testing of tinnitus
Once conditioned, the mice rested for 1 day (day 6).
Then, for 4 consecutive days (days 7 to 10), an active
avoidance task was performed 2 hours after intraperito-
neal injections of saline either alone or containing
300 mg/kg sodium salicylate (Sigma, St. Louis, MO)
[1,2,20]. The active avoidance task consisted of one ses-
sion with 10 trials. To compensate for hearing loss
(threshold elevation of 15 to 20 dB SPL during 4-days
injections in our preliminary, unpublished data) induced
by salicylate injection, the intensity of sound that elicited
the behavioral responses was increased to 70 dB SPL for
the salicylate-treated group. By doing so, the sound sen-
sation levels of all mice in both groups were similar.
During testing, a sound of 3-second duration was
given and the mice were observed for another 5 seconds
to see whether they would climb to the safe area as con-
ditioned (true-positive). If the animals stayed in the safe
area ≥10 seconds, the mice were returned to the floor
for ongoing observation. If the mice did not climb to
the safe area in response to the sound, an electrical
shock was given by the experimenter to remind the
mice to climb to the safe area. Again, if animals stayed
i nt h es a f ea r e a≥1 0s e c ,t h em i c ew e r er e t u r n e dt ot h e
floor for ongoing observation. Finally, the experimenter
observed the total number of times (tinnitus score) the
mice climbed during the inter-trial silent period of
1 minute (false-positive climbs) for 10 trials.
Samples isolation and RNA extraction from cochlea and
IC
The body weights of all mice were measured at day
7 before salicylate or saline injection, and at day
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weights of the midbrain including IC were also mea-
sured before dissection. Paired samples of cochlea and
IC were immediately dissected using a Zeiss stereomi-
croscope and stored in a -80°C freezer until use. RNA
isolation was performed using RNA-Bee isolation
reagent (Friendswood, USA) with a tissue homogenizer
according to the manufacturer’s protocol. RNA quality
was assessed using an Agilent Bioanalyzer 2100 and the
ratio of absorbance measurements at 260 and 280 nm.
Reverse transcription-polymerase chain reaction (RT-PCR)
High quality RNA was used as substrate to synthesize cDNA
by reverse transcription using a MasterAmp™ High Fidelity
RT-PCR Kit (Epicentre Biotechnologies, USA) in a P × 2
Thermal cycler (Thermo Electron Corporation Bioscience
Technologies Division, USA). RT was carried out at 37°C
for 1 hour. For PCR amplification, 7.5 μL cDNA and pri-
mers were used according to the supplier’s instructions. The
primers were: TNF-alpha-F, 5’-CCCCTCAGCAAACCAC-
CAAG-3’, TNF-alpha-R, 5’-CTTGGCAGATTGACCTCA
GC-3’; IL-1beta-F, 5’-GAGTGTGGATCC CAAGCAAT-3’,
IL-1beta-R, 5’-CTCAGTGCAGGCTATGACCA-3’;N M D A
receptor subtype 2B (NR2B)-F, 5’-TCC GCC GAG AGT
CCT CCG T-3’, NR2B-R, 5’-CTG CGT TGC CCT CGA
TGT T-3’; b-actin-F, 5’-CCACACCCGCCACCAGTTCG-
3’,a n db-actin-R, 5’-CCCATTCCCACCATCACACC-3’
(Protech-taiwan, Taiwan).
The thermal cycling conditions for PCR were adjusted
to the following: 3 min initial set-up at 95°C; followed
by 50 cycles of denaturation (45 s at 95°C for all genes),
annealing (45 s at 53°C for TNF-alpha, 52°C for IL-
1beta, 54°C for NR2B, and 50°C for b-actin. A final 10
min extension at 72°C was included for all thermal cycle
runs.
Quantification of PCR products
The DNA products were measured using a Mini Hori-
zontal Electrophoresis System (MJ-105/MP-100, Major
Science, Taiwan) and an E-Box-1000/26M Inspection
Certificate & Analysis Systems (E-Box Spp-010 E-capt
soft ware, USA). The expression levels of TNF-a,I L - 1 b
and NR2B genes are presented as relative ratios in com-
parison to b-actin.
Statistical analysis
Data are presented as mean ± standard deviation (SD),
unless indicated otherwise. Expression levels for the
TNF-a or IL-1b genes, presented as ratios relative to
b-actin, were compared for both groups using Student’s
t-test. The correlation between the tinnitus score
(dependent variable) and TNF-a or IL-1b gene (inde-
pendent variable) expression, and between NR2B
(dependent variable) and TNF-a or IL-1b gene
(independent variable) expression, were analyzed using a
linear regression model. All of the above analyses were
performed using the commercialized software
“STATA10”,a n dp values < 0.05 were considered statis-
tically significant.
Results
The body weight of each mouse did not change signifi-
cantly during active avoidance task conditioning when
performed according to Guitton’s design [2]. The mean
body weight before injection of intraperitoneal salicylate
was 28.4 ± 1.9 g for the salicylate group and 29.0 ± 1.2 g
for the control group (p = 0.1969). On day 4 of tinnitus
induction, mean body weights were still not significantly
different (p = 0.255) between salicylate-treated mice (29.4
± 1.24 g) and control mice (28.8 ± 1.9 g). In addition, the
weights of the midbrain including IC were not signifi-
cantly different between the two groups (0.3 ± 0.03 g sali-
cylate group, 0.3 ± 0.02 g control group, p = 0.6895).
Tinnitus scores, defined as the total number of times
the mice climbed to the safe area during the inter-trial
silent period of 1 minute (false positive climbs) for 10
trials, increased between day 1 and day 4 of intraperito-
neal injections for salicylate-treated mice but did not
increase in the control group. The mean tinnitus score
at day 4 was 0.5 ± 0.5 for the control group and was 8.0
± 1.5 for the salicylate group.
F i g u r e1s h o w st h eg e n ee x p r e s s i o nl e v e l sf o rT N F - a
in cochlea and IC at day 4 after tinnitus induction. in
the salicylate group compared to the control group, the
mean expression level for TNF-a increased significantly
in cochlea (1.89 ± 0.22 vs. 0.87 ± 0.07 respectively, p <
0.0001) and in IC (2.12 ± 0.23 vs. 1.73 ± 0.22 respec-
tively, p = 0.0040). Figure 2 shows expression levels for
Figure 1 Gene expression levels for TNF-a at day 4 after
salicylate injection. mRNA levels increased significantly in both
cochlea and IC in the salicylate-treated group. Values are shown
mean ± SD.
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induction. In the salicylate group compared to the con-
trol group, the mean expression level for the IL-1b gene
increased significantly in cochlea (3.50 ± 1.05 vs. 2.80 ±
0.28, respectively, p < 0.0001) and in IC (2.94 ± 0.51 vs.
1.24 ± 0.52, p = 0.0013).
Table 1 addresses the relationships between tinnitus
scores and gene expression levels for TNF-a, IL-1b, and
NR2B. Linear regression analysis showed that tinnitus
scores were positively associated with gene expression
level of NR2B and with gene expression levels of TNF-a
and IL-1b in cochlea and IC (see Table 1 for data).
In addition, linear regression analysis showed that the
gene expression level of TNF-a was positively associated
with NR2B gene expression in cochlea (b ±S E=1 . 0 7±
0.14, P < 0.001) and in IC (b ± SE = 0.93 ± 0.28, P =
0.001). Similarly, the gene expression level of IL-1b was
positively associated with NR2B gene expression in IC
(b ± SE = 0.24 ± 0.083, P = 0.005), but not in cochlea
(b ± SE = 0.08 ± 0.135, P = 0.575).
Discussion
Considering the results of Weber et al. [8], we suggested
that proinflammatory cytokines, in addition to their con-
tributions to hearing impairment [6,7], might also play
an important role in the pathophysiology of tinnitus.
This experimental study showed that mRNA levels of
the TNF-a and IL-1b genes increased both in cochlea
and IC after intraperitoneal injection of high dose salicy-
late. In addition, the tinnitus scores showed significant
positive associations with the gene expression levels of
TNF-a, IL-1b, and NR2B in both cochlea and IC.
Previous studies have focused on the roles of proin-
flammatory cytokines in hearing impairment. For exam-
ple, virally encoded macrophage inflammatory proteins
appear to play a significant role in cytomegalovirus-
related hearing loss [21]. Cochlear immunohistochemis-
try has confirmed the presence of numerous cytokines,
as well as NF-kB, in otitis media-induced cochlear cyto-
toxicity [22]. TNF-a,I L - 1 ba and IL-6 are significantly
induced in the lateral side of the spiral ligament and
stria vascularis early after noise exposure. Furthermore,
IL-6 is detected in spiral ganglion neurons at 12 and 24
hr after noise exposure. These cytokines may initiate an
inflammatory response and lead to noise-induced
cochlear damage [6,23]. In addition, TNF-a,I L - 1 b and
IL-6 are associated with cisplatin-induced ototoxicity
[7]. However, infusion of TNF-a into the cochlea of gui-
nea pigs does not result in obvious hearing loss,
although inflammatory cells are recruited to the cochlea
[ 2 4 ] .T h er e s u l t so ft h i ss t u d y ,t o g e t h e rw i t ht h o s eo f
Weber et al. [8], suggest that proinflammatory cytokines
might also account for the induction of tinnitus, but the
exact mechanisms involved are still unclear.
Tinnitus can be regarded as phantom auditory pain,
which is often followed by peripheral hearing loss [25].
In chronic neuropathic pain studies, TNF-a,I L - 1 b and
IL-6 have been reported to induce central sensitization
and hyperalgesia after nerve injury via distinct and over-
lapping synaptic mechanisms in superficial dorsal horn
neurons. Furthermore, these proinflammatory cytokines
may induce long-term synaptic plasticity through CREB-
mediated gene transcription [26-30]. It is reasonable to
hypothesize that these cytokines might also contribute
to tinnitus via mechanisms similar to those of post-trau-
matic neuropathic pain.
Tinnitus has been reported to be highly associated
with NMDA receptor activity [2] and/or its gene expres-
sion [5]. Several studies have reported an interaction
between TNF-a and/or IL-1b and functions of NMDA
receptor [9-17]. Conversely, NMDA can also increase
expression of TNF-a and IL-1b,a sw e l la se n d o t h e l i a l
Figure 2 Gene expression levels for IL-1b at day 4 after
salicylate injection. mRNA levels increased significantly in both
cochlea and IC in the salicylate-treated group. Values are shown as
mean ± SD.
Table 1 Relationship between tinnitus scores and
expression levels of TNF-a, IL-1b, and NR2B genes, as
assessed by linear regression analysis
Genes and
sites
Coefficient Standard
error
95% Confident
interval
P
value
TNF-a
Cochlea 6.76 0.49 5.78 ~ 7.74 <0.001
IC 8.79 1.53 5.69 ~ 11.88 <0.001
IL-1b
Cochlea 2.11 0.65 0.80 ~ 3.42 0.002
IC 3.14 0.38 2.38 ~ 3.91 <0.001
NR2B
Cochlea 4.13 0.46 3.20 ~ 5.06 <0.001
IC 2.82 0.92 0.97 ~ 4.67 0.004
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kocyte accumulation in retinal vessels and retina gang-
lion cell death [16]. Glutamate could influence the
release of cellular proinflammatory responses in arthritis
[12]. Therefore, it is also reasonable to hypothesize that
TNF-a and IL-1b might contribute to tinnitus via aug-
menting NMDA receptor expression and/or its
functions.
Conclusion
These data demonstrate that salicylate-induced tinnitus
correlates with increased gene expression of TNF-a and
IL-1b. The tinnitus scores of salicylate-treated mice
showed significant positive associations with the expres-
sion levels of the TNF-a and IL-1b, and NR2B genes.
Furthermore, the gene expression levels of TNF-a and
IL-1b correlated positively with that of the NR2B gene.
We suggest that these proinflammatory cytokines might
lead to tinnitus directly or via modulation of NR2B gene
expression in salicylate-induced tinnitus.
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